TY - JOUR T1 - Substrate-specific recognition of IKKs mediated by USP16 facilitates autoimmune inflammation JF - Science Advances JO - Sci Adv DO - 10.1126/sciadv.abc4009 VL - 7 IS - 3 SP - eabc4009 AU - Yu, Jian-shuai AU - Huang, Tao AU - Zhang, Yu AU - Mao, Xin-tao AU - Huang, Ling-jie AU - Li, Yi-ning AU - Wu, Ting-ting AU - Zhong, Jiang-yan AU - Cao, Qian AU - Li, Yi-yuan AU - Jin, Jin Y1 - 2021/01/01 UR - http://advances.sciencemag.org/content/7/3/eabc4009.abstract N2 - The classic NF-κB pathway plays crucial roles in various immune responses and inflammatory diseases. Its key kinase, IKKβ, participates in a variety of pathological and physiological processes by selectively recognizing its downstream substrates, including p105, p65, and IκBα, but the specific mechanisms of these substrates are unclear. Hyperactivation of one of the substrates, p105, is closely related to the onset of inflammatory bowel disease (IBD) in Nfkb1-deficient mice. In this study, we found that IKKβ ubiquitination on lysine-238 was substantially increased during inflammation. Using mass spectrometry, we identified USP16 as an essential regulator of the IKKβ ubiquitination level that selectively affected p105 phosphorylation without directly affecting p65 or IκBα phosphorylation. Furthermore, USP16 was highly expressed in colon macrophages in patients with IBD, and myeloid-conditional USP16-knockout mice exhibited reduced IBD severity. Our study provides a new theoretical basis for IBD pathogenesis and targeted precision intervention therapy. ER -